Paul Mola is the Founder and CEO of Roswell Biotechnologies. They are working toward the goal of the $100 dollar genome via molecular electronics. In a nutshell, they incorporate DNA polymerase into a circuit and measure the change in current within the circuit (through the polymerase!) as nucleotides move into the active site.
In this episode he describes the journey to get to the $100 genome goal with respect to chip technology and chemistry along with the possibilities for single cell sequencing on a larger scale.
Beyond that, we discuss what he calls the DNA economy. This includes everything from what might eventually be the $10 or $1 genome that will allow us to sequence everything to using DNA as a storage medium. I used to think that was a crazy idea, but once he explained the advantages to me, it made a lot of sense.
This episode is sponsored by Endpoint Communications. They offer customized services for media strategy, thought leadership, content and editorial development – without the hassle of big agency contracts – to help you achieve your business goals faster. To request a free 30-minute consultation, visit endpointcommunications.net and fill out the form at the bottom of the page.